Regeneron shares up 1.4% premarket after earnings top estimates
Marketwatch -

Regeneron Pharmaceuticals Inc. shares rose 1.4% in premarket trade Wednesday, after the company beat consensus estimates for the first quarter. The company posted net income of $974 million, or $8.61 a share, for the quarter, down from $1.115 billion, or $10.09 a share, in the year-earlier period. Adjusted per-share earnings came to $11.49, ahead of the $9.68 FactSet consensus. Revenue rose 17% to $2.965 billion from $2.529 billion a year ago, also ahead of the $2.690 billion FactSet...

Read this story at

Loading...

Related Articles